Surgical Aproach to Perihiliar Cholangiocarcinoma

Main Article Content

Gerardo Israel Zamora Rivera
Marcos Lim Acosta
Paulina Jacqueline Zamora Rivera

Abstract

Cholangiocarcinoma represents a diverse group of epithelial cancers united by late diagnosis and poor outcomes, includes a cluster of highly heterogeneous biliary malignant tumours that can arise at any point of the biliary tree. Global incidence is increasing. Surgical resection is the only potentially curative treatment for patients with cholangiocarcinoma. Due to the incidence of this type of cancer, as well as its associated mortality, a timely diagnosis is necessary, but even more so, to be familiar with the surgical technique, since it is the only potentially curative option for patients suffering from this pathology.

Article Details

How to Cite
Gerardo Israel Zamora Rivera, Marcos Lim Acosta, & Paulina Jacqueline Zamora Rivera. (2022). Surgical Aproach to Perihiliar Cholangiocarcinoma. International Journal of Medical Science and Clinical Research Studies, 2(9), 975–976. https://doi.org/10.47191/ijmscrs/v2-i9-13
Section
Articles

References

I. Razumilava N, Gores GJ. Cholangiocarcinoma. The Lancet. 2014;383(9935):2168-2179.

doi:10.1016/S0140-6736(13)61903-0

II. Banales JM, Marin JJG, Lamarca A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nature Reviews Gastroenterology & Hepatology 2020 17:9. 2020;17(9):557-588. doi:10.1038/s41575-020-0310-z

III. Forner A, Vidili G, Rengo M, Bujanda L, Ponz-Sarvisé M, Lamarca A. Clinical presentation, diagnosis and staging of cholangiocarcinoma. Liver International. 2019;39(S1):98-107.

doi:10.1111/LIV.14086

IV. Rodrigues PM, Olaizola P, Paiva NA, et al. Pathogenesis of Cholangiocarcinoma. https://doi.org/101146/annurev-pathol-030220-020455. 2021;16:433-463.

doi:10.1146/ANNUREV-PATHOL-030220-020455

V. Morise, Z., Sugioka, A., Tokoro, T., Tanahashi, Y., Okabe, Y., Kagawa, T., & Takeura, C. (2010). Surgery and chemotherapy for intrahepatic cholangiocarcinoma. World journal of hepatology, 2(2), 58.

VI. Cillo U, Fondevila C, Donadon M, et al. Surgery for cholangiocarcinoma. Liver International. 2019;39(S1):143-155. doi:10.1111/LIV.14089

VII. Imventarza O. Article in Chinese Clinical Oncology. Clin Oncol. Published online 2018.

doi:10.21037/cco.2018.07.02

VIII. Rangarajan K, Simmons G, Manas D, Malik H, Hamady ZZ. Systemic adjuvant chemotherapy for cholangiocarcinoma surgery: A systematic review and meta-analysis. European Journal of Surgical Oncology. 2020;46(4):684-693.

doi:10.1016/J.EJSO.2019.11.499